If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1995-2002 M.D., School of Medicine, Taipei Medical University

Experience

  • 2019 Director, Department for Quality Management, Taipei Medical University Shuang Ho Hospital
  • 2007.08- Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2016.08- Assistant Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
  • 2012.11-2016.07 Lecture, Department of Internal Medicine, School of Medicine, Taipei Medical University

Awards

  • 2013 Excellent Junior Research Investigator

Research Interests

  • Nephrology
  • Meta-analysis

Fingerprint Dive into the research topics where Mei-Yi Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Chronic Renal Insufficiency Medicine & Life Sciences
Kidney Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Carbon Monoxide Poisoning Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Dialysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2019

建立IgA腎炎免疫表現型與免疫組庫特徵達到非侵入性疾病診斷與治療監控

Wu, M.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

新聘教師研究補助

Wu, M.

4/1/173/31/18

Project: B - Project of TMUg - Research Grants for Newly Hired Faculty

探討micro RNA135-a/b在糖尿病引發慢性腎病變的模式中與轉型生長因子beta的 關係及所扮演的生理及分子的角色

Wu, M.

5/1/154/30/16

Project: C - Project of Alliancet - Taipei Medical University Shuang Ho Hospital

糖尿病腎病變惡化之全基因組關聯研究

Wu, M.

6/1/145/31/15

Project: C - Project of Alliancet - Taipei Medical University Shuang Ho Hospital

Research Output 2007 2019

  • 389 Citations
  • 10 h-Index
  • 41 Article
  • 3 Review article
  • 2 Comment/debate

Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population

Zheng, C. M., Wang, J. Y., Chen, T. T., Wu, Y. C., Wu, Y. L., Lin, H. T., Chiu, S. P., Chang, T. J., Zheng, J. Q., Chu, N. F., Lin, Y. M., Su, S. L., Lu, K. C., Chen, J. S., Sung, F. C., Lee, C. T., Yang, Y., Hwang, S. J., Wang, M. C., Hsu, Y. H. & 4 others, Chiou, H. Y., Kao, S., Wu, M. Y. & Lin, Y. F., Dec 1 2019, In : Scientific Reports. 9, 1, 2694.

Research output: Contribution to journalArticle

Open Access
Angiotensin Receptor Antagonists
Chronic Renal Insufficiency
Angiotensin-Converting Enzyme Inhibitors
Angiotensins
Kidney

Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients

Kao, C. C., Cheng, S. Y., Wang, Y. J., Chien, S. C., Hsu, Y. W., Wu, M. Y., Lu, H. F., Nam, S., Sun, T., Wu, M. S. & Chang, W. C., Jun 5 2019, In : BMC Nephrology. 20, 1, 203.

Research output: Contribution to journalArticle

Open Access
Endothelins
Chronic Kidney Failure
Bacteremia
Infection
Single Nucleotide Polymorphism
Renal Dialysis
Meta-Analysis
Catheters
Confidence Intervals
Incidence

Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study

Cho, P. J-Y., Wu, C-Y., Johnston, J., Wu, M-Y., Shu, C-C. & Lin, H-H., May 1 2019, In : International Journal of Tuberculosis and Lung Disease. 23, 5, p. 555-562 8 p.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Observational Studies
Tuberculosis
Cohort Studies
Glomerular Filtration Rate